DB-105

N/A

Report date: 2023/08/07 17:46:05
NME

Base Information

Drug NameDB-105
Drug Alias NameORM-12741DB-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2c adrenergic receptor antagonists
TargetsAlpha-2c adrenergic receptor
Therapy Area/IndicationsRaynaud DiseaseAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsSouth AfricaUnited Kingdom +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesDenovo Biopharma Llc
Inactive CompaniesJanssen Pharmaceuticals IncUniversity Of Cape TownOrion Corporation Orion Pharma
Active IndicationsAlzheimer Disease
Inactive IndicationsRaynaud Disease

Other Information

ATC CodeN/A
Related LinksN/A